Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Brandon O’Brien, the Chief Financial Officer of CorVel Corp (NASDAQ:CRVL), a $5.63 billion market cap company with a GREAT financial health rating according to InvestingPro, recently sold shares of the company’s common stock, according to a filing submitted to the Securities and Exchange Commission. On February 19, O’Brien sold a total of 1,512 shares at an average price of $117.54 per share, amounting to a total transaction value of $177,721.
Following this sale, O’Brien holds 15,630 shares of CorVel’s common stock. The transaction was executed as a direct sale, and there was no equity swap involved. The filing was signed by Sharon O’Connor on behalf of O’Brien and was submitted on February 21.
In other recent news, CorVel Corporation reported strong financial results for the fourth quarter of 2024, with earnings per share (EPS) increasing by 39% to $0.46, surpassing market expectations. The company also reported a 13% year-over-year revenue growth, reaching $228 million, which exceeded forecasts and demonstrated robust financial performance. CorVel attributes this success to its continued investment in AI and automation, enhancing its service offerings in the healthcare sector. Additionally, the company completed a 3-for-1 stock split in December 2024, reflecting its strong financial position. During the quarter, CorVel repurchased 85,710 shares for $9.6 million, maintaining a strong cash position with a balance of $163 million. The company remains committed to expanding its technological capabilities to improve patient outcomes and operational efficiency. CorVel’s strategic initiatives and financial results have been met with optimism from investors, as indicated by the positive market reaction following the earnings announcement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.